RABALKEM LS 75/20MG CAPSULE is a combination of Levosulpiride and Rabeprazole which belongs to the group of medicines called Dopamine D2 antagonists and Proton-pump inhibitors respectively. RABALKEM LS 75/20MG CAPSULE is indicated for the management of Gastro-esophageal reflux disease (GERD). GERD is a chronic digestive disease in which the stomach acid frequently flows into the esophagus leading to irritation and inflammation of lining of food pipe. Symptoms include heartburn, chest pain, nausea, sensation of lump in throat and stomach discomfort.
RABALKEM LS 75/20MG CAPSULE can also be used to manage peptic ulcer (painful sores in the gut), Zollinger-Ellison syndrome (tumors in pancreas causing the stomach to secrete more acid), functional dyspepsia (recurrent signs and symptoms of indigestion without an obvious cause) and diabetic gastroparesis (delayed gastric emptying caused due to diabetes).
Take RABALKEM LS 75/20MG CAPSULE preferably on an empty stomach. Avoid consumption of alcohol while taking RABALKEM LS 75/20MG CAPSULE as it could potentiate the CNS depressive side effects.
Patients receiving long-term management (>1 year) with RABALKEM LS 75/20MG CAPSULE should be kept on regular surveillance because it can increase the risk of bone fracture (i.e., in the hip, wrist or spine) which is more predominant in the patients having osteoporosis or taking corticosteroids.
Before taking RABALKEM LS 75/20MG CAPSULE, inform your doctor if you have any heart, kidney or liver disease as a precaution. RABALKEM LS 75/20MG CAPSULE is not recommended for use in pregnant or breastfeeding women, including children and adolescents (aged below 18 years).
The most common side effects of taking RABALKEM LS 75/20MG CAPSULE are nausea, vomiting, stomach pain, diarrhea, constipation and headache. Consult your doctor if any of these symptoms worsen.
No content available
